Share
Publications
-
12 October 2006 /Prices and reimbursement
Consumption of antibiotics 2000 – 2005
The past years' development of the consumption of antibiotics has shown that the consumption has increased greatly for several broad-spectrum products. The reason for this may be the increasing extent of prescriptions of broad-spectrum products for infections not requiring such treatment.
-
31 July 2006 /Prices and reimbursement
Examination of single reimbursement for medicinal products
On behalf of Merck Sharp & Dohme (MSD), Tranberg Marketing Rekommandation has examined general practitioners' knowledge, experience and attitude to single reimbursement for medicine ("Praktiserende lægers kendskab, erfaring og holdning til enkelttilskud til medicin"). The examination is based on telephone interviews with 282 general practitioners.
-
06 June 2006 /Prices and reimbursement
-
02 June 2006 /Prices and reimbursement
Consumption of benzodiazepines and benzodiazepine related drugs (cyclopyrrolones)
During the 4th quarter 2003 it was decided that a range of initiatives were to be launched with the purpose of maintaining and strengthening the current tendency of a total decreasing consumption of benzodiazepines (sleeping medicine, tranquilisers and anti-anxiety agents) as well as cyclopyrrolones.
-
16 March 2006 /Prices and reimbursement
Changed consumption of hormones for menopausal women
The quantity consumption of hormones by women with menopausal discomfort has fallen drastically after announcements of increased risk of breast cancer. This is the finding of a consumption analysis performed by the Danish Medicines Agency on the basis of data from the Register of Medicinal Product Statistics.
-
23 February 2006 /Prices and reimbursement
Dose dispensing in the primary health sector - the last 6 months of 2005
During the first 6 months of 2005, approximately 26.000 people had their medicinal products dose dispensed. Elderly women constitute the main part of this group. The consumption of dose dispensed medicinal products amounts to 1.6 per cent of the total consumption of medicinal products during the first 6 months of 2005.
